ASCO GI 2023 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO GI 2023 Conference Coverage

Videos

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO GI 2023 Survival Analysis of the Phase II Randomized DEEPER Trial by JACCRO: m-FOLFOXIRI + Cetuximab vs. m-FOLFOXIRI + Bevacizumab as Initial Treatment for Unresectable RAS & BRAF Wild-Type mCRC

By ASCO GI 2023 Conference Coverage FEATURING Yu Sunakawa

0 views

January 20, 2023

Comments 0

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Videos